Guangdong Hec Technology Holding Co Ltd
SSE:600673
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Guangdong Hec Technology Holding Co Ltd
Operating Income
Guangdong Hec Technology Holding Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Guangdong Hec Technology Holding Co Ltd
SSE:600673
|
Operating Income
¥1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
|
|
C
|
China Hongqiao Group Ltd
HKEX:1378
|
Operating Income
¥36.7B
|
CAGR 3-Years
35%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Aluminum Corporation of China Ltd
SSE:601600
|
Operating Income
¥33B
|
CAGR 3-Years
26%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Shandong Hongchuang Aluminum Industry Holding Co Ltd
SZSE:002379
|
Operating Income
¥26.8B
|
CAGR 3-Years
794%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Yunnan Aluminium Co Ltd
SZSE:000807
|
Operating Income
¥8.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
31%
|
CAGR 10-Years
62%
|
|
|
Tianshan Aluminum Group Co Ltd
SZSE:002532
|
Operating Income
¥6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
51%
|
|
Guangdong Hec Technology Holding Co Ltd
Glance View
Nestled in the vibrant economic landscape of China, Guangdong Hec Technology Holding Co Ltd operates with the intricacies of a well-oiled machine in the health sector. The company, with its focal point in pharmaceuticals, has been a significant player in the development, manufacturing, and sale of a variety of medicinal products. Its portfolio spans across anti-infectives, digestive medications, and cardiovascular treatments, amassing a reputation for innovation and quality. The company’s commitment to research and development is palpable, as it consistently invests in state-of-the-art laboratories and collaborations with leading scientific minds. This approach not only fuels its pipeline of groundbreaking therapies but also ensures a steady stream of products ready for market. The company's revenue engine hums efficiently through a strategic blend of domestic and international market penetration. By leveraging an extensive distribution network, Guangdong Hec Technology ensures its products reach both regional pharmacies and global pharmaceutical markets. Through meticulous marketing strategies and strategic partnerships, the company has adeptly navigated the complex waters of regulatory compliance and competitive pricing landscapes. Its financial fortitude is further bolstered by a judicious mix of pharmaceutical exports and local sales, highlighting its dual focus on global expansion and domestic consolidation. In this dance of science and commerce, Guangdong Hec Technology continues to solidify its stature, harnessing both innovation and keen business acumen to thrive in the ever-evolving pharmaceutical industry.
See Also
What is Guangdong Hec Technology Holding Co Ltd's Operating Income?
Operating Income
1.2B
CNY
Based on the financial report for Dec 31, 2025, Guangdong Hec Technology Holding Co Ltd's Operating Income amounts to 1.2B CNY.
What is Guangdong Hec Technology Holding Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
13%
Over the last year, the Operating Income growth was 158%.